Tergene Biotech gets recommendation from CDSCO subject expert committee for pneumococcal 15-valent vaccine
Tergene Biotech gets recommendation from CDSCO subject expert committee for pneumococcal 15-valent vaccine
Source: freepressjournal.in
Page 5 - Pneumococcal News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pneumococcal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pneumococcal Today - Breaking & Trending Today
Pfizer Inc.: Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union
Positive pivotal top-line data demonstrates 20-valent pneumococcal conjugate vaccine candidate (20vPnC), if approved, can likely help protect against all 20 vaccine serotypes in three-dose series
Source: finanznachrichten.de
Merck & Co., Inc.: Merck Receives Positive CHMP Opinion for VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) in Infants and Children
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the
Source: finanznachrichten.de
Pfizer: Phase 3 Study Of 20-Valent Pneumococcal Conjugate Vaccine Posts Positive Results In Infants
NEW YORK CITY (dpa-AFX) - Drug major Pfizer Inc. (PFE) announced Friday positive top-line results from its pivotal U.S. Phase 3 study (NCT04382326) evaluating its 20-valent pneumococcal conjugate
Source: finanznachrichten.de
PCV13 pneumococcal vaccine reduces risk of acute chest syndrome in kids with sickle cell anemia: JAMA
France: Implementing a 13-valent pneumococcal conjugate vaccine (PCV13) in the general pediatric population may reduce the incidence of acute chest syndrome (ACS) in children with sickle-cell disease...
Source: medicaldialogues.in